Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
002007 Hualan Biological Engineering, Inc.
- 16.26
- -0.11-0.67%
Market Closed Apr 25 15:00 CST
29.74BMarket Cap27.33P/E (TTM)
16.53High16.22Low117.96KlotVolume16.41Open16.37Pre Close192.95MTurnover0.75%Turnover Ratio27.33P/E (Static)1.83BShares19.9852wk High2.51P/B25.59BFloat Cap13.7252wk Low18.01Limit Up1.57BShs Float74.90Historical High14.73Limit Down1.89%Amplitude-2.28Historical Low0.30Dividend TTM16.36Avg Price60.66KlotAsk1.85%Div YieldTTM100Lot Size53.40KlotBid
Hualan Biological Engineering, Inc. News
Hualan Biotech: An indicative announcement on the postponement of the replacement of the board of directors and the board of supervisors
Hualan Biotech: Announcement on the use of own funds for investment and financial management
Hualan Biotech: Announcement on changing the registered capital and amending the relevant provisions of the “Articles of Association”
Hualan Biotech: Notice of Annual General Meeting of Shareholders
Hualan Biotech: Notice on Repurchase and Cancellation of Certain Restricted Shares, Changes in Registered Capital and Notification to Creditors
Hualan Biotech: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2024 and the performance of supervisory duties by the Audit Committee of the Board of Directors
Hualan Biotech: Announcement on the company\'s acquisition of a single plasma sampling license
Hualan Biotech: Announcement on the Shareholding Company Obtaining an Acceptance Notice for Drug Registration
Hualan Biotech: Announcement on participating companies obtaining drug registration certificates
Hualan Biotech: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Hualan Biological Engineering, Inc.: Notice on the approval of the establishment of a single blood plasma collection station by a wholly-owned subsidiary.
Hualan Biological Engineering, Inc.: Announcement regarding the price adjustment of the main products of the holding subsidiary.
Hualan Biological Engineering, Inc.: Announcement on the company's acquisition of a single plasma sampling license
Hualan Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Hualan Bioengineering Co., Ltd.
Hualan Biology: Legal Opinion of Anhui Chengyi Law Firm on Hualan Bioengineering Co., Ltd. holding the 2023 Annual General Meeting of Shareholders
Hualan Biotech: “Rules of Procedure for the Nomination Committee of the Board of Directors”
Hualan Biotech: “Rules of Work of the Board Strategy Committee”
Hualan Biotech: Rules of Procedure for the Board of Directors of Hualan Bioengineering Co., Ltd.
Hualan Biotech: The company's shareholder return plan for the next three years (2024-2026)
Hualan Biology: Internal Control Self-Evaluation Report
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs